ConductScience.org, home

Paper40433232

Current Status of Gastric Cancer Screening and Future Perspectives.

Kusano C and 3 others. DEN Open, 2026. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Current Status of Gastric Cancer Screening and Future Perspectives. Papers, record 40433232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40433232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Current Status of Gastric Cancer Screening and Future Perspectives.
PubMed
Journal
DEN Open
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.83, provisional
iCite
Revised in PubMed
2025-05-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kusano CChikahttps://orcid.org/0000-0002-3789-4787
2Ishibashi FFumiaki
3Ichita CChikamasahttps://orcid.org/0000-0001-9210-7371
4Gotoda TTakuji

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111190068The role of economic evaluation in the diagnosis and treatment of Helicobacter pylori infection.Gastroenterol Clin North Am2000https://conductscience.org/library/papers/11190068PubMed
211876711The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial.Aliment Pharmacol Ther2002https://conductscience.org/library/papers/11876711PubMed
326651251Screening of gastric cancer in Asia.Best Pract Res Clin Gastroenterol2015https://conductscience.org/library/papers/26651251PubMed
428147224Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality.Gastroenterology2017https://conductscience.org/library/papers/28147224PubMed
524236091A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan.PLoS One2013https://conductscience.org/library/papers/24236091PubMed
633538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
728279154Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests.BMC Cancer2017https://conductscience.org/library/papers/28279154PubMed
834278663Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis.Helicobacter2021https://conductscience.org/library/papers/34278663PubMed
916331632Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan.Int J Cancer2006https://conductscience.org/library/papers/16331632PubMed
1010382118Helicobacter pylori and gastric cancer: what are the benefits of screening only for the CagA phenotype of H. pylori?Helicobacter1999https://conductscience.org/library/papers/10382118PubMed
1115548353Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma.Neoplasia2004https://conductscience.org/library/papers/15548353PubMed
1239126193Cost-effective endoscopic screening for gastric cancer in a cohort with low Helicobacter pylori prevalence.J Gastroenterol Hepatol2024https://conductscience.org/library/papers/39126193PubMed
1331190581Cost-effectiveness of Helicobacter pylori test and eradication versus upper gastrointestinal series versus endoscopy for gastric cancer mortality and outcomes in high prevalence countries.Scand J Gastroenterol2019https://conductscience.org/library/papers/31190581PubMed
1431648970The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017.Lancet Gastroenterol Hepatol2020https://conductscience.org/library/papers/31648970PubMed
1521741639Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis.Gastrointest Endosc2011https://conductscience.org/library/papers/21741639PubMed
1625314140Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: a systematic review and meta-analysis.PLoS One2014https://conductscience.org/library/papers/25314140PubMed
1735531944Gastric cancer screening: a systematic review and meta-analysis.Scand J Gastroenterol2022https://conductscience.org/library/papers/35531944PubMed
1817912238X-ray screening seems to reduce gastric cancer mortality by half in a community-controlled trial in Costa Rica.Br J Cancer2007https://conductscience.org/library/papers/17912238PubMed
1930242605How long should we continue gastric cancer screening? From an epidemiological point of view.Gastric Cancer2019https://conductscience.org/library/papers/30242605PubMed
2017505999Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study.Scand J Gastroenterol2007https://conductscience.org/library/papers/17505999PubMed

See all 45 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42428146Global stomach cancer burden from high-sodium diet and smoking: 1990-2021 findings & 2040 projections.Front Oncol2026https://conductscience.org/library/papers/42428146PubMed
42075532Prevention of Gastric Cancer.Medicina (Kaunas)2026https://conductscience.org/library/papers/42075532PubMed
41867005Cancer mortality predictions for 2026 in selected Asian countries and Australia with focus on prostate cancer.Eur J Cancer Prev2026https://conductscience.org/library/papers/41867005PubMed
41859297The Value of the Preoperative Hematological Inflammatory Markers for Predicting Lymphovascular Invasion in Gastric Cancer.Immunotargets Ther2026https://conductscience.org/library/papers/41859297PubMed
41824387The role of phase angle and standardized phase angle in assessing nutritional status and predicting complications in gastrointestinal cancer.PLoS One2026https://conductscience.org/library/papers/41824387PubMed
41347071Enhancing cancer risk awareness and screening management through artificial intelligence: a narrative review.Front Oncol2025https://conductscience.org/library/papers/41347071PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40433232

GET https://conductscience.org/api/papers/v1/40433232/references?page=2